Natl. Drug Code Directory
Executive Summary
The revised 1985 two volume directory contains a list of approximately 34,000 Rx drug products marketed in the U.S. The first volume contains an alphabetical index by product name and the second volume contains numeric indices by drug class, by natl. drug code and an alphabetical index of Rx drug labelers. New edition now includes the NDA, ANDA, or form 5 number for approximately 40% of the listed drugs. The directory, prepared by FDA's Drug Listing Branch, is available from the Government Printing Office, (202) 783-3238. Price is $76/domestic, $95/foreign. Order number 917-00900000-7.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.